Some Minnesota medical device companies are highlighting a new study that says delays by the Food and Drug Administration are putting U.S firms at a disadvantage against their European counterparts.
The study, which was funded in part by the medical device industry, finds that European regulators are approving new products at a much faster rate than the FDA.
To read the full article by Tom Scheck, Minnesota Public Radio, click here.
Latest from Today's Medical Developments
- Boston Scientific to acquire Penumbra, expanding cardiovascular portfolio
- Star Cutter introduces Double Pilot Reamer
- #80 Manufacturing Matters - Machining Strategies to Save Time and Improve your Process for MedTech Components with Kennametal Inc.
- Real-world parts and expert manufacturing advice
- Experts discuss the latest in toolholding technology
- How permanent magnets are powering medical innovation
- Forecasting the year ahead in design and manufacturing
- Tecomet, Orchid Orthopedic Solutions announce merger agreement